Lipella Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -131.0% | -131.0% | -92.7% |
| FY2022 | -55.6% | -55.6% | -43.7% |
| FY2023 | -146.9% | -146.9% | -129.1% |
| FY2024 | -261.3% | -261.3% | -187.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -131.0% | -131.0% | -92.7% |
| FY2022 | -55.6% | -55.6% | -43.7% |
| FY2023 | -146.9% | -146.9% | -129.1% |
| FY2024 | -261.3% | -261.3% | -187.6% |